Published September 30, 2026 | Version v1

One Health Approach to Rabies Elimination in India: Progress, Operational Bottlenecks, and Innovative Interventions

Description

Dog-mediated human rabies continues to be one of the most inequitably distributed vaccine-
preventable zoonoses of our time, and India has historically carried a disproportionate share of this global 
burden. The launch of the National Action Plan for Rabies Elimination by 2030 (NAPRE 2030) marked a 
deliberate policy shift away from siloed, reactive, sector-specific responses toward an operationalised One 
Health framework that binds together human health authorities, veterinary and animal husbandry 
departments, urban local bodies, and forest and wildlife agencies under a common elimination target. This 
review synthesises the evolving epidemiological picture, the policy architecture of NAPRE 2030, the 
persistent ground-level operational bottlenecks that slow programme delivery, and the technological and 
biomedical innovations now reshaping the Indian rabies-control landscape. Importantly, this update 
incorporates the most recent nationally representative estimate of disease burden — a 2022–23 
community-based decision-tree modelling survey that places annual human rabies mortality in India at 
approximately 5,726 deaths, a substantial downward revision from the long-cited figure of nearly 20,000 
deaths, reflecting both genuine programmatic gains and improved epidemiological measurement. Ground-
level constraints discussed include unmanaged free-roaming dog (FRD) demography sustained by open 
municipal solid waste, structural and financial limits on Animal Birth Control (ABC)/Catch-Neuter-
Vaccinate-Release (CNVR) programmes, rural cold-chain fragility, chronic Rabies Immunoglobulin (RIG) 
supply deficits, and socio-culturally embedded delays in wound care. Against these constraints, the review 
evaluates a cluster of converging innovations — Oral Rabies Vaccination (ORV) sachets for catch-resistant 
dogs, recombinant human monoclonal antibodies (mAbs) progressively displacing serum-derived 
immunoglobulins, WHO-endorsed one-week intradermal (ID) dose-sparing post-exposure prophylaxis 
(PEP), digital and mobile spatial surveillance platforms, next-generation messenger RNA (mRNA) and self-
amplifying RNA rabies vaccine candidates, and unmanned aerial vehicle (UAV)-assisted last-mile biologic 
delivery. Field-validated regional models from Goa and Sikkim are examined as proof of operational 
concept for the Indian socio-ecological setting. The review concludes with a set of strategic, resource-
conscious recommendations — institutional, financial, and community-facing — necessary if India is to 
convert the stated ambition of NAPRE 2030 into a verified, internationally recognised elimination of dog-
mediated human rabies.

Files

9. BVI SEPTEMBER ISSUE 90-105.pdf

Files (805.1 kB)

Name Size
md5:8301cdcb246b98e86b87d9ff8c78ef2e
805.1 kB Preview Download